Core Viewpoint - The critical point of the articles is that critical illness insurance, once a leading product in the health insurance market, is now facing marginalization due to the rise of affordable alternatives like "Hui Min Bao" and million-dollar medical insurance, prompting the introduction of short-term critical illness insurance products with high leverage and low premiums [1][2]. Group 1: Market Dynamics - The emergence of short-term critical illness insurance products, such as those offering coverage of one million yuan for a premium of around 100 yuan, represents a significant shift in the market, aiming to attract consumers with lower costs and higher coverage [2][3]. - The transition to new definitions of critical illness insurance in 2021 led to a sharp decline in sales, indicating a challenging environment for traditional long-term products [1][2]. Group 2: Product Comparison - Long-term critical illness insurance typically offers coverage for 20 to 30 years or even a lifetime, while short-term products are generally annual, leading to differences in pricing, coverage responsibilities, and target demographics [4][5]. - Short-term critical illness insurance can alleviate the cost issue associated with traditional products, making insurance more accessible to a broader audience, particularly younger individuals or those with specific health concerns [3][4]. Group 3: Future Outlook - Industry experts believe that while short-term critical illness insurance has price advantages, it is unlikely to replace traditional long-term products due to limitations in coverage and the uncertainty of renewals as individuals age [6][7]. - Long-term critical illness insurance remains essential for families seeking comprehensive health coverage, especially in the context of an aging population and rising healthcare costs [6][7].
进入“百元保百万”时代 杠杆率改变能否重构重疾险市场？